KORRO BIO, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.74 USD | +0.72% |
|
-11.73% | -7.03% |
| May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
| May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 51.30 | 90.00 | 90.00 |
| Spread/Res. | -13.14% | -50.49% | -50.49% |
| Spread/Supp. | -0.40% | +8.63% | +16.44% |
| Support | 44.74 | 41.02 | 38.27 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- KRRO Stock
- Charts Korro Bio, Inc.
